Ustekinumab
- Level
- Commodity
- Parent
- 51202400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51202414This classification denotes a monoclonal antibody with the molecular formula C6482H10004N1712O2016S46, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FU77B4U5Z0, more generally known as ustekinumab. European Medicines Agency schedules ustekinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27761. The term USTEKINUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 1, 2009, list 61. Most nations, for tariff and trade purposes, schedule Ustekinumab under HS 30021020 and SITC 54163. SMILES:. As of Q4 2014, USTEKINUMAB remains US FDA's Preferred Term for this commodity. . Ustekinumab bears US NLM identifiers UMLS ID C1608841 and NCI Concept Code C84237.
Same parent
Under 51202400 · 21Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.